Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12623001091695Phase 4Recruiting
Phase 4, randomised trial in postoperative pain comparing Subacromial ropivacaine with Subacromial saline placebo (2 arms). Primary endpoint: Post-operative morphine equivalent dose. Started May 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12623001091695.